How big is the Hyperhidrosis Treatment Market?

The Hyperhidrosis Treatment Market size is expected to reach USD 656.72 million in 2024 and grow at a CAGR of 5.56% to reach USD 860.76 million by 2029. Read More

What is the current Hyperhidrosis Treatment Market size?

In 2024, the Hyperhidrosis Treatment Market size is expected to reach USD 656.72 million. Read More

Who are the key players in Hyperhidrosis Treatment Market?

AbbVie Inc., Eli Lilly (Dermira), Advin Health Care, Dermavant (Roivant Sciences) and Brickell Biotech Inc. are the major companies operating in the Hyperhidrosis Treatment Market. Read More

Which is the fastest growing region in Hyperhidrosis Treatment Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Hyperhidrosis Treatment Market?

In 2024, the North America accounts for the largest market share in Hyperhidrosis Treatment Market. Read More

What years does this Hyperhidrosis Treatment Market cover, and what was the market size in 2023?

In 2023, the Hyperhidrosis Treatment Market size was estimated at USD 620.21 million. The report covers the Hyperhidrosis Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Hyperhidrosis Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Hyperhidrosis Treatment Market Share

Statistics for the 2023 & 2024 Hyperhidrosis Treatment market share, created by Mordor Intelligence™ Industry Reports. Hyperhidrosis Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Hyperhidrosis Treatment Industry

The hyperhidrosis treatment market is moderately competitive and consists of several major players. The prominent players in the market are AbbVie, Brickell Biotech, Eli Lilly and Company (Dermira), Advin Healthcare, and Dermavant Scienecs Inc. (Roivant Sci), among others. The companies operating in the market are focusing on R&D investments and fundraising activities to conduct clinical trials that lead to strong product pipelines.